Skip to content

Septerna, Inc. SEPN Operating margin

Operating margin at other companies

Amgen logo
AmgenAMGN
28.4%+6.6pp
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
-577.5%-597pp
Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
-439.3%+35.3pp
Fortrea Holdings Inc. logo
Fortrea Holdings Inc.FTRE
-13.1%-4.1pp
Precigen logo
PrecigenPGEN
-2,890.9%
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
44.8%+1.6pp

Other financials

Income statement

See full
Revenue$26.5M+12,011%
Operating income-$13.3M+48.7%
Net income-$8.6M+59.8%
EPS (diluted)-$0.19+61.2%

Balance sheet

See full
Cash & equivalents$71.6M-65.9%
Total debt$23.1M-7.7%
Total equity$378.5M+195%
Total assets$569.7M+31.3%

Cash flow

See full
Operating cash flow-$25.6M-9.8%
CapEx$832.0K+118%
Free cash flow-$26.5M-11.5%

Valuation

See full
Market cap$1.65B+319%
Enterprise value$1.6B+1,325%
P/S22.8×-379×

Profitability

See full
Net margin-49.9%-24.9pp
FCF margin467.9%+243pp

Returns & leverage

See full
Return on equity-12.2%
Debt / equity0.1×
Current ratio4.7×-27.5×

Where this comes from

Calculated from Septerna, Inc.’s reported figures.

Based on trailing twelve months.

The official record: Septerna, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Septerna, Inc.'s operating margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Septerna, Inc.'s operating margin?
Septerna, Inc. (SEPN) reported operating margin of -77.1% in Q1 2026.
How has Septerna, Inc.'s operating margin changed year-over-year?
Septerna, Inc.'s operating margin increased by 99.2% year-over-year, from -9,339.1% to -77.1%.
What does operating margin mean?
Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.